11 Dec 2014 @ 21:50
£3.5 million Placing to Accelerate Growth, Conversion of Loan Notes and Grant of Options Fitbug Holdings Plc, the AIM quoted provider of online personal health and wellbeing services, has announced that it has successfully raised £3,510,200 (before expenses) through Hybridan LLP by way of a placing of 39,002,224 new ordinary shares of 1 pence each […]
09 Dec 2014 @ 21:40
The MoU consolidates the talks held by the companies this year and marks the starting point for the specific projects that the companies have already identified. Abengoa (MCE: ABG.B/P SM) (Nasdaq:ABGB), the international company that applies innovative technology solutions for sustainability in the energy and environment sectors, signed a memorandum of understanding in Seoul on […]
08 Dec 2014 @ 21:46
Who is the new member of the board? Northrop Grumman Corporation (
NYSE:NOC) announced today that its board of directors has elected Kenneth L. Bedingfield, corporate vice president and chief financial officer, effective after the company files its 2014 annual report. Bedingfield will succeed James F. Palmer, who has announced his intention to retire in 2015. […]
08 Dec 2014 @ 21:43
Protection in the U.S. Novadaq Technologies Inc. (Nasdaq:NVDQ) (TSX:NDQ), a developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced the recent grant of United States Patent No. 8,892,190 entitled “Method and Apparatus for Performing Intra-Operative Angiography.” NOVADAQ’s most recent U.S...
07 Dec 2014 @ 11:36
Expression of Genes Involved in T-cell Function and Hematopoietic Stem Cell Engraftment Significantly Increased Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, released preclinical data today highlighting the pharmacological properties of ex vivo programmed hematopoietic cells...
03 Dec 2014 @ 10:27
Fitbug Holdings shares (
LSE:FITB) have risen from a strange base in a determination to go upwards. The base is called a strange base because it was ongoing for many months (an extremely tight consolidation), while price appears as dots in the chart. However, the current upwards breakout signals the end of the tight consolidation. The […]
25 Nov 2014 @ 23:43
Optibiotix stock (
LSE:OPTI) has gone upwards significantly and it is expected that the substantial gains made by the bulls would be sustained. In this market, short-term pullbacks should be seen as another money making opportunities by the bulls. When speculating on a new bias, what you think is a new bias may simple be a […]
25 Nov 2014 @ 23:34
Phorm Corporation shares (
LSE:PHRM) is a bear market and it would remain so for some time to come. The recent bullish run peaked in September 2014, after which a bearish bias started. Therefore, the last near-term rally that has happened in this month is a good opportunity to sell short and ride the market downwards. […]
25 Nov 2014 @ 20:46
Did it go with a bang? Northrop Grumman Corporation (
NYSE:NOC) recently supported the successful flight testing of the U.S. Air Force’s Minuteman III intercontinental ballistic missile (ICBM) weapon system. The operational flight test was conducted as part of the Air Force Global Strike Command’s Force Development Evaluation Program. This program demonstrates and supports...
20 Nov 2014 @ 22:59
The share price of Intel (
NASDAQ:INTC) rose steadily this morning, then spiked upward as the news reported by the board of directors at the company’s annual shareholder’s meeting became public. Opening this morning at 34.15, shares gained to 4.66% to close the day at 35.95, the highest the Intel share price has closed since February […]